|
|
Volumn 16, Issue SUPPL. 2, 2006, Pages 511-514
|
|
An update on ovarian suppression/ablation
|
|
Author keywords
Chemotherapy; Early breast cancer; Goserelin; LHRHa; Ovarian ablation; Ovarian suppression; Tamoxifen
|
|
Indexed keywords
AROMATASE INHIBITOR;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EXEMESTANE;
FLUOROURACIL;
GONADORELIN DERIVATIVE;
GOSERELIN;
LEUPRORELIN;
METHOTREXATE;
TAMOXIFEN;
TRIPTORELIN;
ALOPECIA;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER THERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE FREE SURVIVAL;
DRUG TOLERABILITY;
HOT FLUSH;
HUMAN;
IRRADIATION;
MORBIDITY;
NAUSEA;
OVARIECTOMY;
OVARY SUPPRESSION;
PREMENOPAUSE;
PRIORITY JOURNAL;
RECURRENT DISEASE;
UNSPECIFIED SIDE EFFECT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
OVARIECTOMY;
PREMENOPAUSE;
|
|
EID: 33748796052
PISSN: 1048891X
EISSN: 15251438
Source Type: Journal
DOI: 10.1111/j.1525-1438.2006.00683.x Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (0)
|
